Allogene Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0197701065

SecurityALLO / Allogene Therapeutics, Inc.
InstitutionTd Asset Management Inc
Latest Disclosed Ownership652,484 shares
Latest Disclosed Value $ 1,592,061
Td Asset Management Inc reports 57.58% increase in ownership of ALLO / Allogene Therapeutics, Inc.

On May 11, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 652,484 shares of Allogene Therapeutics, Inc. (US:ALLO) valued at $1,592,061 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 414,074 shares of Allogene Therapeutics, Inc.. This represents a change in shares of 57.58% during the quarter. The current value of the position is $1,226,670 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 652,484 238,410 57.58 1,592 180.78 0.0007
2026-02-10 2025-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 414,074 0 0.00 567 10.53 0.0005
2025-11-10 2025-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 414,074 -131,314 -24.08 513 -16.72 0.0004
2025-07-28 2025-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 545,388 0 0.00 616 -22.61 0.0005
2025-05-07 2025-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 545,388 0 0.00 796 -31.44 0.0007
2025-02-11 2024-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 545,388 -131,752 -19.46 1,162 -41.07 0.0010
2024-11-01 2024-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 677,140 -122,200 -15.29 1,970 5.80 0.0017
2024-08-02 2024-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 799,340 361,904 82.73 1,862 -4.76 0.0017
2024-05-08 2024-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 437,436 199,600 83.92 1,955 156.23 0.0018
2024-02-12 2023-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 237,836 0 0.00 763 1.33 0.0008
2023-10-27 2023-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 237,836 38,357 19.23 754 -24.02 0.0009
2023-08-09 2023-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 199,479 25,800 14.85 991 15.64 0.0011
2023-05-10 2023-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 173,679 0 0.00 858 -21.52 0.0010
2023-02-07 2022-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 173,679 9,000 5.47 1,092 -35.73 0.0013
2022-11-07 2022-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 164,679 36,706 28.68 1,699 16.45 0.0021
2022-08-04 2022-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 127,973 5,600 4.58 1,459 30.85 0.0017
2022-05-10 2022-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 122,373 13,200 12.09 1,115 -31.55 0.0007
2022-02-10 2021-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 109,173 -2,192 -1.97 1,629 -43.08 0.0014
2021-11-09 2021-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 111,365 19,689 21.48 2,862 42.25 0.0030
2021-08-11 2021-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 91,676 10,171 12.48 2,012 -30.07 0.0020
2021-05-14 2021-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 81,505 3,632 4.66 2,877 46.34 0.0032
2021-02-16 2020-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 77,873 192 0.25 1,966 -32.88 0.0024
2020-11-10 2020-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 77,681 -4,800 -5.82 2,929 -17.07 0.0041
2020-08-13 2020-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 82,481 28,206 51.97 3,532 234.79 0.0050
2020-05-15 2020-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 54,275 -3,600 -6.22 1,055 -29.85 0.0018
2020-02-11 2019-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 57,875 0 0.00 1,504 -4.63 0.0022
2019-11-07 2019-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 57,875 0 0.00 1,577 1.48 0.0024
2019-08-01 2019-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 57,875 32,232 125.70 1,554 109.72 0.0023
2019-05-08 2019-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 25,643 600 2.40 741 9.94 0.0011
2019-02-01 2018-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 25,043 25,043 674 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.